These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3521442)

  • 1. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirmenol: preclinical pharmacology.
    Kaplan HR; Mertz TE; Steffe TJ
    Angiology; 1988 Mar; 39(3 Pt 2):281-92. PubMed ID: 3281517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
    Hampton EM; Anderson JL; Lutz JR; Nappi JM
    Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    J Cardiovasc Pharmacol; 1986; 8(1):156-60. PubMed ID: 2419679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
    Cardona F; Seide H; Cox RA; Pérez CM
    P R Health Sci J; 2003 Jun; 22(2):119-23. PubMed ID: 12866134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study.
    Rehnqvist N
    Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
    Gimeno Gascon JV; Algarra Vidal FJ
    Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.